Chemical inhibitors of connexin 39 can target the protein through a variety of mechanisms to inhibit its function. Carbenoxolone, for instance, binds directly to connexin 39, effectively blocking the gap junction channels that are essential for cells to communicate with each other. This binding leads to a closure of the channels, preventing the flow of ions and other signaling molecules. 18-α-Glycyrrhetinic acid, on the other hand, disrupts the assembly of connexin 39 into functional gap junctions, which is a critical step in the formation of these intercellular communication channels. By preventing the proper assembly, this compound ensures that the channels do not form correctly, thus inhibiting the protein's function. Similarly, 2-APB alters the gating mechanism of connexin 39 channels, which affects their permeability. By changing how these channels open and close, 2-APB can reduce the transfer of signaling molecules between cells. Flufenamic acid and mefenamic acid also inhibit connexin 39 by directly modulating the activity of its channels, decreasing the likelihood that the channels will be in an open state, and therefore, reducing intercellular communication.
Heptanol and octanol interfere with the lipid environment of the cell membrane where connexin 39 is situated. This disruption destabilizes the gap junctions that connexin 39 forms, thereby inhibiting its function and the protein's ability to mediate cellular communication. Halothane affects the functionality of connexin 39 by altering the fluidity of the cell membrane, which is a critical factor for the proper functioning of gap junction channels. Quinine and quinidine act as channel blockers for connexin 39, physically obstructing the passage through the gap junction channels and thus inhibiting the flow of ions and small molecules. Baicalein is believed to inhibit connexin 39 by influencing its phosphorylation state or its interaction with other cellular proteins, which are necessary for its function in gap junction communication. Lastly, Gap19 is a peptide specifically designed to bind to connexin proteins, including connexin 39, blocking its hemichannels. These hemichannels contribute to direct cell-to-cell communication and the passage of signaling molecules, and their inhibition by Gap19 leads to a decrease in functional intercellular communication mediated by connexin 39.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Carbenoxolone | 5697-56-3 | sc-507294 | 1 g | $50.00 | ||
Carbenoxolone can inhibit connexin 39 by binding directly to the connexin protein, thereby blocking gap junction intercellular communication channels that connexin 39 forms. | ||||||
18 β-Glycyrrhetinic Acid | 471-53-4 | sc-205573B sc-205573 sc-205573A sc-205573C sc-205573D | 1 g 5 g 10 g 25 g 100 g | $28.00 $54.00 $85.00 $129.00 $313.00 | 3 | |
18-α-Glycyrrhetinic acid can inhibit connexin 39 by disrupting its subunit assembly, preventing the formation of functional gap junctions which connexin 39 constitutes. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
2-APB can functionally inhibit connexin 39 by altering the channel gating, affecting the permeability and conductance of connexin 39 gap junctions. | ||||||
Flufenamic acid | 530-78-9 | sc-205699 sc-205699A sc-205699B sc-205699C | 10 g 50 g 100 g 250 g | $26.00 $77.00 $151.00 $303.00 | 1 | |
Flufenamic acid can inhibit connexin 39 by modulating the channel activity, thus reducing gap junction-mediated intercellular communication that involves connexin 39. | ||||||
Mefenamic acid | 61-68-7 | sc-205380 sc-205380A | 25 g 100 g | $104.00 $204.00 | 6 | |
Mefenamic acid can inhibit connexin 39 by directly affecting its channel activity, leading to a decrease in the intercellular communication facilitated by connexin 39. | ||||||
Quinine | 130-95-0 | sc-212616 sc-212616A sc-212616B sc-212616C sc-212616D | 1 g 5 g 10 g 25 g 50 g | $77.00 $102.00 $163.00 $347.00 $561.00 | 1 | |
Quinine can block the gap junction channels formed by connexin 39, inhibiting the intercellular communication that is mediated by connexin 39. | ||||||
Quinidine | 56-54-2 | sc-212614 | 10 g | $102.00 | 3 | |
Quinidine can inhibit connexin 39 by blocking the gap junction channels, disrupting the intercellular communication that connexin 39 facilitates. | ||||||
Baicalein | 491-67-8 | sc-200494 sc-200494A sc-200494B sc-200494C | 10 mg 100 mg 500 mg 1 g | $31.00 $41.00 $159.00 $286.00 | 12 | |
Baicalein can reduce gap junction communication involving connexin 39, likely through the modulation of its phosphorylation state or interaction with associated proteins. | ||||||